Description
A mixture of ganglioside GM3 with C18:1 and C20:1 sphingoid backbones; demonstrates antiproliferative and pro-apoptotic effects in tumor cells by modulating cell adhesion, proliferation, and differentiation; suppresses angiogenesis and reduces proliferation and migration of HUVECs at 20 μM; induces dissociation of the insulin receptor-caveolin-1 complex from lipid microdomains,
Formal name:
Synonyms: Hematoside Mixture|Sialosyllactosylceramide Mixture
Molecular weight: 1,180.50
CAS: 54827-14-4
Purity: ≥98%
Formulation: A lyophilized solid
Product Type|Biochemicals|Lipids|Sphingolipids||Research Area|Cancer|Angiogenesis||Research Area|Cancer|Cell Death|Apoptosis||Research Area|Cancer|Cell Migration & Metastasis||Research Area|Cancer|Cell Signaling|Growth Factor Receptor Signaling||Research Area|Cardiovascular System|Vasculature|Angiogenesis||Research Area|Cardiovascular System|Vasculature|Endothelium||Research Area|Cell Biology|ECM & Adhesion Molecules||Research Area|Endocrinology & Metabolism|Metabolic Diseases|Diabetes||Research Area|Lipid Biochemistry|Sphingolipids